文献速递心胸血管麻醉术前评估与围术期医学

SCA临床实践更新:心脏手术相关急性肾损伤管理

Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery.
PubMed 文献 · Anesth Analg · 2022-05-12

心脏手术相关急性肾损伤(CS-AKI)常见且增加术后并发症与死亡风险。SCA工作组基于15项RCT的荟萃分析,采用GRADE方法评估6种潜在肾保护策略,建议在高危患者中使用CPB目标导向氧输送和KDIGO集束化治疗(中等证据),血管麻痹性休克可考虑血管加压素(低证据),限制性与开放性输血决策不应基于肾脏保护考虑(中等证据)。

要点

  • 高危患者使用CPB目标导向氧输送和KDIGO集束化治疗可预防CS-AKI(中等证据)。
  • 血管麻痹性休克患者可考虑使用血管加压素以减少CS-AKI(低证据)。
  • 围术期输血策略选择不应基于肾脏保护考虑(中等证据)。

核心结论

  • 基于15项RCT的荟萃分析,建议高危患者使用CPB目标导向氧输送和KDIGO集束化治疗以预防CS-AKI(中等GRADE证据)。
  • 血管麻痹性休克患者可考虑使用血管加压素减少CS-AKI(低GRADE证据)。
  • 限制性与开放性红细胞输注策略的选择不应基于肾脏保护考虑(中等GRADE证据)。
  • CPB期间 targeting higher mean arterial pressure、围术期使用多巴胺和右美托咪定未减少CS-AKI(低或极低GRADE证据)。

研究设计与样本

  • SCA持续实践改进急性肾损伤工作组基于RCT证据提供的实践更新。
  • 全面检索PubMed、EMBASE和Cochrane图书馆从建库至2021年2月,更新至2021年8月。
  • 纳入15项RCT进行荟萃分析,评估6种策略对CS-AKI的影响。
  • 采用GRADE方法评估每种策略的证据等级。

主要发现

  • 6种潜在肾保护策略的现有证据等级为中等、低或极低。
  • CPB目标导向氧输送和KDIGO集束化治疗在高危患者中预防CS-AKI的证据等级为中等。
  • 血管加压素用于血管麻痹性休克减少CS-AKI的证据等级为低。
  • 限制性与开放性输血策略对肾脏保护无差异的证据等级为中等。
  • CPB期间更高平均动脉压目标、围术期多巴胺和右美托咪定未减少CS-AKI的证据等级为低或极低。

关键数值与推荐

  • 建议高危患者使用CPB目标导向氧输送和KDIGO集束化治疗预防CS-AKI(中等GRADE证据)。
  • 血管麻痹性休克患者可考虑使用血管加压素减少CS-AKI(低GRADE证据)。
  • 限制性与开放性红细胞输注策略的选择不应基于肾脏保护考虑(中等GRADE证据)。
  • CPB期间 targeting higher mean arterial pressure、围术期多巴胺和右美托咪定未减少CS-AKI(低或极低GRADE证据)。

临床怎么用

  • 对高危心脏手术患者,考虑实施CPB目标导向氧输送和KDIGO集束化治疗以预防CS-AKI。
  • 血管麻痹性休克患者可考虑使用血管加压素以减少CS-AKI。
  • 围术期红细胞输注策略不应以肾脏保护为由选择限制性或开放性策略。
  • 不推荐仅以肾脏保护为目的 targeting higher mean arterial pressure during CPB、使用多巴胺或右美托咪定。

局限性

  • 证据等级总体为中等、低或极低,部分策略证据质量有限。
  • 检索截止2021年8月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiac surgery-associated acute kidney injury (CS-AKI) is common and is associated with increased risk for postoperative morbidity and mortality. Our recent survey of the Society of Cardiovascular Anesthesiologists (SCA) membership showed 6 potentially renoprotective strategies for which clinicians would most value an evidence-based review (ie, intraoperative target blood pressure, choice of specific vasopressor agent, erythrocyte transfusion threshold, use of alpha-2 agonists, goal-directed oxygen delivery on cardiopulmonary bypass [CPB], and the "Kidney Disease Improving Global Outcomes [KDIGO] bundle of care"). Thus, the SCA's Continuing Practice Improvement Acute Kidney Injury Working Group aimed to provide a practice update for each of these strategies in cardiac surgical patients based on the evidence from randomized controlled trials (RCTs). PubMed, EMBASE, and Cochrane library databases were comprehensively searched for eligible studies from inception through February 2021, with search results updated in August 2021. A total of 15 RCTs investigating the effects of the above-mentioned strategies on CS-AKI were included for meta-analysis. For each strategy, the level of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Across the 6 potentially renoprotective strategies evaluated, current evidence for their use was rated as "moderate," "low," or "very low." Based on eligible RCTs, our analysis suggested using goal-directed oxygen delivery on CPB and the "KDIGO bundle of care" in high-risk patients to prevent CS-AKI (moderate level of GRADE evidence). Our results suggested considering the use of vasopressin in vasoplegic shock patients to reduce CS-AKI (low level of GRADE evidence). The decision to use a restrictive versus liberal strategy for perioperative red cell transfusion should not be based on concerns for renal protection (a moderate level of GRADE evidence). In addition, targeting a higher mean arterial pressure during CPB, perioperative use of dopamine, and use of dexmedetomidine did not reduce CS-AKI (a low or very low level of GRADE evidence). This review will help clinicians provide evidence-based care, targeting improved renal outcomes in adult patients undergoing cardiac surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Peng K, McIlroy DR, Bollen BA, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery. Anesth Analg. 2022. PMID: 35544772. doi:10.1213/ANE.0000000000006068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。